Macrogenics (MGNX) Depreciation and Depletion (2012 - 2020)
Macrogenics (MGNX) reported Depreciation and Depletion of $2.9 million for Q4 2020, down 4.21% year-over-year from $3.1 million in Q1 2020, and down 0.98% quarter-over-quarter from $3.0 million in Q3 2020.
Macrogenics (MGNX) Depreciation and Depletion (2012 - 2020) Analysis & Trends
Macrogenics (MGNX) has 7 years of Depreciation and Depletion data on file, last reported at $2.9 million in Q4 2020.
- Depreciation and Depletion for Q4 2020 came in at $2.9 million, down 4.21% year-over-year; the trailing twelve-month figure through Dec 2020 was $12.0 million (up 28.33% YoY), and the FY2025 annual result was $7.2 million, down 4.0% from the prior year.
- Depreciation and Depletion declined to $2.9 million in Q4 2020 per MGNX's latest filing, from $3.0 million in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $3.1 million in Q4 2019 and troughed at $1.2 million in Q4 2016.
- A 3-year average of $2.4 million and a median of $2.5 million in 2016 frame the typical range for Depreciation and Depletion.
- On a YoY basis, Depreciation and Depletion climbed as much as 324.74% in 2016 and fell as far as 23.74% in 2016.
- A 3-year view of Depreciation and Depletion shows it stood at $1.2 million in 2016, then jumped by 162.61% to $3.1 million in 2019, then decreased by 4.21% to $2.9 million in 2020.
- Business Quant data shows MGNX's Depreciation and Depletion at $2.9 million in Q4 2020, $3.0 million in Q3 2020, and $3.1 million in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Macrogenics | 260.14 Mn | 193.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2.93 Mn |
| Dec 31, 2020 | 2.93 Mn |
| Sep 30, 2020 | 2.96 Mn |
| Sep 30, 2020 | 2.96 Mn |
| Dec 31, 2019 | 3.06 Mn |
| Dec 31, 2019 | 3.06 Mn |
| Sep 30, 2019 | 3.06 Mn |
| Sep 30, 2019 | 3.06 Mn |
| Dec 31, 2016 | 1.17 Mn |
| Dec 31, 2016 | 1.17 Mn |
| Sep 30, 2016 | 2.08 Mn |
| Sep 30, 2016 | 2.08 Mn |
| Jun 30, 2016 | 1.79 Mn |
| Jun 30, 2016 | 1.79 Mn |
| Mar 31, 2016 | 1.77 Mn |
| Mar 31, 2016 | 1.77 Mn |
| Dec 31, 2015 | 1.53 Mn |
| Dec 31, 2015 | 1.53 Mn |
| Sep 30, 2015 | 489,000.00 |
| Sep 30, 2015 | 489,000.00 |